Phase 1 trial of 17-AAG in patients with relapsed and refractory multiple myeloma (MM) No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2005 ASCO Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback